Follow the people · Insider
Raymond Anderson
Raymond Anderson files insider transactions with the SEC as a director of Monopar Therapeutics (MNPR). We hold 2 disclosed purchases and sales filed since 31 May 2006, 2 of them in the last 90 days.
- Files forMNPR
- Disclosed buys and sells2 in all, 2 in the last 90 days
- Last disclosure28 August 2026
Positions held
5 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 31 January 2020 — 25 August 2026Director · Monopar Therapeutics (MNPR)52 Form 4 lines · source: SEC Form 4
- Filed 9 August 2018 — 9 August 2018Director · Monopar Therapeutics (NONE)1 Form 4 line · source: SEC Form 4
- Filed 14 June 2007 — 25 October 2016Director · Raptor Pharmaceutical (RPTP)84 Form 4 lines · source: SEC Form 4
- Filed 29 September 2009 — 29 September 2009Director · Raptor Pharmaceutical (RPTPD)2 Form 4 lines · source: SEC Form 4
- Filed 26 May 2006 — 26 May 2006Director · Highland Clan Creations (HCLN)1 Form 4 line · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 1,402 shares of Monopar TherapeuticsSEC Form 428 August 2026Common Stock · traded 25 August 2026 · filed 28 August 2026
- exercised options over 1,740 shares of Monopar TherapeuticsSEC Form 428 August 2026Common Stock · traded 25 August 2026 · filed 28 August 2026
- ▼ sold on the open market 694 shares of Monopar TherapeuticsSEC Form 428 August 2026Common Stock · traded 25 August 2026 · filed 28 August 2026
- ▼ sold on the open market 646 shares of Monopar TherapeuticsSEC Form 428 August 2026Common Stock · traded 25 August 2026 · filed 28 August 2026
- ▼ sold on the open market 1,802 shares of Monopar TherapeuticsSEC Form 428 August 2026Common Stock · traded 25 August 2026 · filed 28 August 2026
- exercised options over 1,402 shares of Monopar Therapeutics (a derivative holding)SEC Form 428 August 2026Stock Option · traded 25 August 2026 · filed 28 August 2026
- exercised options over 1,740 shares of Monopar Therapeutics (a derivative holding)SEC Form 428 August 2026Stock Option · traded 25 August 2026 · filed 28 August 2026
- ▼ sold on the open market 694 shares of Monopar TherapeuticsSEC Form 427 August 2026Common Stock · traded 25 August 2026 · filed 27 August 2026
- ▼ sold on the open market 646 shares of Monopar TherapeuticsSEC Form 427 August 2026Common Stock · traded 25 August 2026 · filed 27 August 2026
- ▼ sold on the open market 1,802 shares of Monopar TherapeuticsSEC Form 427 August 2026Common Stock · traded 25 August 2026 · filed 27 August 2026
- was granted 2,924 shares of Monopar Therapeutics (a derivative holding)SEC Form 48 December 2025Stock Options · traded 2 December 2025 · filed 8 December 2025
- was granted 11,365 shares of Monopar Therapeutics (a derivative holding)SEC Form 47 March 2025Stock Options · traded 4 March 2025 · filed 7 March 2025
- exercised options over 2,533 shares of Monopar Therapeutics (a derivative holding)SEC Form 43 January 2024Restricted Stock Units · traded 31 December 2023 · filed 3 January 2024
- exercised options over 2,533 shares of Monopar TherapeuticsSEC Form 43 January 2024Common Stock · traded 31 December 2023 · filed 3 January 2024
- exercised options over 2,533 shares of Monopar Therapeutics (a derivative holding)SEC Form 43 October 2023Restricted Stock Units · traded 30 September 2023 · filed 3 October 2023
- exercised options over 2,533 shares of Monopar TherapeuticsSEC Form 43 October 2023Common Stock · traded 30 September 2023 · filed 3 October 2023
- exercised options over 2,534 shares of Monopar Therapeutics (a derivative holding)SEC Form 43 July 2023Restricted Stock Units · traded 30 June 2023 · filed 3 July 2023
- exercised options over 2,534 shares of Monopar TherapeuticsSEC Form 43 July 2023Common Stock · traded 30 June 2023 · filed 3 July 2023
- exercised options over 2,533 shares of Monopar Therapeutics (a derivative holding)SEC Form 44 April 2023Restricted Stock Units · traded 31 March 2023 · filed 4 April 2023
- exercised options over 2,533 shares of Monopar TherapeuticsSEC Form 44 April 2023Common Stock · traded 31 March 2023 · filed 4 April 2023
- was granted 13,930 shares of Monopar Therapeutics (a derivative holding)SEC Form 43 February 2023Stock Options · traded 1 February 2023 · filed 3 February 2023
- was granted 10,133 shares of Monopar Therapeutics (a derivative holding)SEC Form 43 February 2023Restricted Stock Units · traded 1 February 2023 · filed 3 February 2023
- exercised options over 2,859 shares of Monopar Therapeutics (a derivative holding)SEC Form 43 January 2023Restricted Stock Units · traded 31 December 2022 · filed 3 January 2023
- exercised options over 2,859 shares of Monopar TherapeuticsSEC Form 43 January 2023Common Stock · traded 31 December 2022 · filed 3 January 2023
- exercised options over 2,859 shares of Monopar Therapeutics (a derivative holding)SEC Form 43 October 2022Restricted Stock Units · traded 30 September 2022 · filed 3 October 2022
- exercised options over 2,859 shares of Monopar TherapeuticsSEC Form 43 October 2022Common Stock · traded 30 September 2022 · filed 3 October 2022
- exercised options over 2,859 shares of Monopar Therapeutics (a derivative holding)SEC Form 41 July 2022Restricted Stock Units · traded 30 June 2022 · filed 1 July 2022
- exercised options over 2,859 shares of Monopar TherapeuticsSEC Form 41 July 2022Common Stock · traded 30 June 2022 · filed 1 July 2022
- exercised options over 2,859 shares of Monopar Therapeutics (a derivative holding)SEC Form 41 April 2022Restricted Stock Units · traded 31 March 2022 · filed 1 April 2022
- exercised options over 2,859 shares of Monopar TherapeuticsSEC Form 41 April 2022Common Stock · traded 31 March 2022 · filed 1 April 2022
- was granted 15,128 shares of Monopar Therapeutics (a derivative holding)SEC Form 44 February 2022Stock Options · traded 2 February 2022 · filed 4 February 2022
- was granted 11,436 shares of Monopar Therapeutics (a derivative holding)SEC Form 44 February 2022Restricted Stock Units · traded 2 February 2022 · filed 4 February 2022
- exercised options over 751 shares of Monopar Therapeutics (a derivative holding)SEC Form 44 January 2022Restricted Stock Units · traded 31 December 2021 · filed 4 January 2022
- exercised options over 751 shares of Monopar TherapeuticsSEC Form 44 January 2022Common Stock · traded 31 December 2021 · filed 4 January 2022
- exercised options over 751 shares of Monopar Therapeutics (a derivative holding)SEC Form 41 October 2021Restricted Stock Units · traded 30 September 2021 · filed 1 October 2021
- exercised options over 751 shares of Monopar TherapeuticsSEC Form 41 October 2021Common Stock · traded 30 September 2021 · filed 1 October 2021
- exercised options over 752 shares of Monopar Therapeutics (a derivative holding)SEC Form 42 July 2021Restricted Stock Units · traded 30 June 2021 · filed 2 July 2021
- exercised options over 752 shares of Monopar TherapeuticsSEC Form 42 July 2021Common Stock · traded 30 June 2021 · filed 2 July 2021
- exercised options over 751 shares of Monopar TherapeuticsSEC Form 41 April 2021Common Stock · traded 31 March 2021 · filed 1 April 2021
- exercised options over 751 shares of Monopar Therapeutics (a derivative holding)SEC Form 41 April 2021Restricted Stock Units · traded 31 March 2021 · filed 1 April 2021
- was granted 4,443 shares of Monopar Therapeutics (a derivative holding)SEC Form 428 January 2021Stock Options · traded 26 January 2021 · filed 28 January 2021
- was granted 3,005 shares of Monopar Therapeutics (a derivative holding)SEC Form 428 January 2021Restricted Stock Units · traded 26 January 2021 · filed 28 January 2021
- exercised options over 322 shares of Monopar TherapeuticsSEC Form 45 January 2021Common Stock · traded 30 September 2020 · filed 5 January 2021
- exercised options over 322 shares of Monopar TherapeuticsSEC Form 45 January 2021Common Stock · traded 31 December 2020 · filed 5 January 2021
- exercised options over 322 shares of Monopar Therapeutics (a derivative holding)SEC Form 45 January 2021Restricted Stock Units · traded 30 September 2020 · filed 5 January 2021
- exercised options over 322 shares of Monopar Therapeutics (a derivative holding)SEC Form 45 January 2021Restricted Stock Units · traded 31 December 2020 · filed 5 January 2021
- exercised options over 323 shares of Monopar Therapeutics (a derivative holding)SEC Form 42 July 2020Restricted Stock Units · traded 30 June 2020 · filed 2 July 2020
- exercised options over 323 shares of Monopar TherapeuticsSEC Form 42 July 2020Common Stock · traded 30 June 2020 · filed 2 July 2020
- exercised options over 322 shares of Monopar Therapeutics (a derivative holding)SEC Form 41 April 2020Restricted Stock Units · traded 31 March 2020 · filed 1 April 2020
- exercised options over 322 shares of Monopar TherapeuticsSEC Form 41 April 2020Common Stock · traded 31 March 2020 · filed 1 April 2020
- was granted 1,289 shares of Monopar Therapeutics (a derivative holding)SEC Form 420 February 2020Restricted Stock Units · traded 31 January 2020 · filed 20 February 2020
- was granted 5,646 shares of Monopar Therapeutics (a derivative holding)SEC Form 420 February 2020Stock Options · traded 31 January 2020 · filed 20 February 2020
- was granted 26,100 shares of Monopar Therapeutics (a derivative holding)SEC Form 427 September 2018Stock options · traded 9 August 2018 · filed 27 September 2018
- disposed of in a tender offer 6,695 shares of Raptor PharmaceuticalSEC Form 426 October 2016Common Stock · traded 24 October 2016 · filed 26 October 2016
- returned to the issuer 8,330 shares of Raptor PharmaceuticalSEC Form 426 October 2016Common Stock · traded 25 October 2016 · filed 26 October 2016
- returned to the issuer 30,000 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 426 October 2016Stock Option (right to buy) · traded 25 October 2016 · filed 26 October 2016
- returned to the issuer 90,000 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 426 October 2016Stock Option (right to buy) · traded 25 October 2016 · filed 26 October 2016
- returned to the issuer 120,000 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 426 October 2016Stock Option (right to buy) · traded 25 October 2016 · filed 26 October 2016
- returned to the issuer 50,000 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 426 October 2016Stock Option (right to buy) · traded 25 October 2016 · filed 26 October 2016
- was granted 8,330 shares of Raptor PharmaceuticalSEC Form 427 June 2016Common Stock · traded 23 June 2016 · filed 27 June 2016
- exercised options over 4,916 shares of Raptor PharmaceuticalSEC Form 44 September 2015Common Stock · traded 2 September 2015 · filed 4 September 2015
- ▼ sold on the open market 4,916 shares of Raptor PharmaceuticalSEC Form 44 September 2015Common Stock · traded 2 September 2015 · filed 4 September 2015
- exercised options over 4,916 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 44 September 2015Stock options (right to buy) · traded 2 September 2015 · filed 4 September 2015
- exercised options over 8,084 shares of Raptor PharmaceuticalSEC Form 42 September 2015Common Stock · traded 31 August 2015 · filed 2 September 2015
- ▼ sold on the open market 8,084 shares of Raptor PharmaceuticalSEC Form 42 September 2015Common Stock · traded 31 August 2015 · filed 2 September 2015
- exercised options over 8,084 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 42 September 2015Stock options (right to buy) · traded 31 August 2015 · filed 2 September 2015
- was granted 5,021 shares of Raptor PharmaceuticalSEC Form 421 May 2015Common Stock · traded 19 May 2015 · filed 21 May 2015
- was granted 18,996 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 421 May 2015Stock options (right to buy) · traded 19 May 2015 · filed 21 May 2015
- exercised options over 11,313 shares of Raptor PharmaceuticalSEC Form 426 March 2015Common Stock · traded 24 March 2015 · filed 26 March 2015
- exercised options over 8,306 shares of Raptor PharmaceuticalSEC Form 426 March 2015Common Stock · traded 24 March 2015 · filed 26 March 2015
- exercised options over 2,000 shares of Raptor PharmaceuticalSEC Form 426 March 2015Common Stock · traded 24 March 2015 · filed 26 March 2015
- ▼ sold on the open market 21,619 shares of Raptor PharmaceuticalSEC Form 426 March 2015Common Stock · traded 24 March 2015 · filed 26 March 2015
- exercised options over 11,313 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 426 March 2015Stock options (right to buy) · traded 24 March 2015 · filed 26 March 2015
- exercised options over 8,306 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 426 March 2015Stock options (right to buy) · traded 24 March 2015 · filed 26 March 2015
- exercised options over 2,000 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 426 March 2015Stock options (right to buy) · traded 24 March 2015 · filed 26 March 2015
- was granted 1,674 shares of Raptor PharmaceuticalSEC Form 411 February 2015Common Stock · traded 9 February 2015 · filed 11 February 2015
- was granted 6,332 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 411 February 2015Stock options (right to buy) · traded 9 February 2015 · filed 11 February 2015
- exercised options over 10,000 shares of Raptor PharmaceuticalSEC Form 414 January 2015Common Stock · traded 12 January 2015 · filed 14 January 2015
- ▼ sold on the open market 10,000 shares of Raptor PharmaceuticalSEC Form 414 January 2015Common Stock · traded 12 January 2015 · filed 14 January 2015
- exercised options over 10,000 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 414 January 2015Stock options (right to buy) · traded 12 January 2015 · filed 14 January 2015
- exercised options over 10,000 shares of Raptor PharmaceuticalSEC Form 412 September 2014Common Stock · traded 10 September 2014 · filed 12 September 2014
- ▼ sold on the open market 10,000 shares of Raptor PharmaceuticalSEC Form 412 September 2014Common Stock · traded 10 September 2014 · filed 12 September 2014
- exercised options over 10,000 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 412 September 2014Stock options (right to buy) · traded 10 September 2014 · filed 12 September 2014
- exercised options over 27,500 shares of Raptor PharmaceuticalSEC Form 49 July 2014Common Stock · traded 7 July 2014 · filed 9 July 2014
- ▼ sold on the open market 27,500 shares of Raptor PharmaceuticalSEC Form 49 July 2014Common Stock · traded 7 July 2014 · filed 9 July 2014
- exercised options over 27,500 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 49 July 2014Stock options (right to buy) · traded 7 July 2014 · filed 9 July 2014
- exercised options over 12,500 shares of Raptor PharmaceuticalSEC Form 411 March 2014Common Stock · traded 7 March 2014 · filed 11 March 2014
- ▼ sold on the open market 12,500 shares of Raptor PharmaceuticalSEC Form 411 March 2014Common Stock · traded 7 March 2014 · filed 11 March 2014
- exercised options over 12,500 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 411 March 2014Stock options (right to buy) · traded 7 March 2014 · filed 11 March 2014
- was granted 50,000 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 411 February 2014Stock options (right to buy) · traded 7 February 2014 · filed 11 February 2014
- exercised options over 10,000 shares of Raptor PharmaceuticalSEC Form 49 January 2014Common Stock · traded 7 January 2014 · filed 9 January 2014
- ▼ sold on the open market 10,000 shares of Raptor PharmaceuticalSEC Form 49 January 2014Common Stock · traded 7 January 2014 · filed 9 January 2014
- exercised options over 10,000 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 49 January 2014Stock options (right to buy) · traded 7 January 2014 · filed 9 January 2014
- exercised options over 15,000 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 412 November 2013Stock options (right to buy) · traded 7 November 2013 · filed 12 November 2013
- exercised options over 15,000 shares of Raptor PharmaceuticalSEC Form 412 November 2013Common Stock · traded 7 November 2013 · filed 12 November 2013
- ▼ sold on the open market 14,400 shares of Raptor PharmaceuticalSEC Form 412 November 2013Common Stock · traded 7 November 2013 · filed 12 November 2013
- ▼ sold on the open market 600 shares of Raptor PharmaceuticalSEC Form 412 November 2013Common Stock · traded 7 November 2013 · filed 12 November 2013
- exercised options over 15,000 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 411 September 2013Stock options (right to buy) · traded 9 September 2013 · filed 11 September 2013
- exercised options over 15,000 shares of Raptor PharmaceuticalSEC Form 411 September 2013Common Stock · traded 9 September 2013 · filed 11 September 2013
- ▼ sold on the open market 15,000 shares of Raptor PharmaceuticalSEC Form 411 September 2013Common Stock · traded 9 September 2013 · filed 11 September 2013
- exercised options over 2,000 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 431 December 2012Stock options (right to buy) · traded 28 December 2012 · filed 31 December 2012
- exercised options over 2,000 shares of Raptor PharmaceuticalSEC Form 431 December 2012Common Stock · traded 28 December 2012 · filed 31 December 2012
- ▼ sold on the open market 2,000 shares of Raptor PharmaceuticalSEC Form 431 December 2012Common Stock · traded 28 December 2012 · filed 31 December 2012
- exercised options over 2,000 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 41 October 2012Stock options (right to buy) · traded 1 October 2012 · filed 1 October 2012
- exercised options over 2,000 shares of Raptor PharmaceuticalSEC Form 41 October 2012Common Stock · traded 1 October 2012 · filed 1 October 2012
- ▼ sold on the open market 2,000 shares of Raptor PharmaceuticalSEC Form 41 October 2012Common Stock · traded 1 October 2012 · filed 1 October 2012
- was granted 50,000 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 427 September 2012Stock options (right to buy) · traded 25 September 2012 · filed 27 September 2012
- exercised options over 2,000 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 414 September 2012Stock option (right to buy) · traded 12 September 2012 · filed 14 September 2012
- exercised options over 2,000 shares of Raptor PharmaceuticalSEC Form 414 September 2012Common Stock · traded 12 September 2012 · filed 14 September 2012
- ▼ sold on the open market 2,000 shares of Raptor PharmaceuticalSEC Form 414 September 2012Common Stock · traded 12 September 2012 · filed 14 September 2012
- exercised options over 35 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 411 June 2012Stock options (right to buy) · traded 7 June 2012 · filed 11 June 2012
- exercised options over 35 shares of Raptor PharmaceuticalSEC Form 411 June 2012Common Stock · traded 7 June 2012 · filed 11 June 2012
- ▼ sold on the open market 35 shares of Raptor PharmaceuticalSEC Form 411 June 2012Common Stock · traded 7 June 2012 · filed 11 June 2012
- exercised options over 1,965 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 411 June 2012Stock options (right to buy) · traded 8 June 2012 · filed 11 June 2012
- exercised options over 1,965 shares of Raptor PharmaceuticalSEC Form 411 June 2012Common Stock · traded 8 June 2012 · filed 11 June 2012
- ▼ sold on the open market 1,965 shares of Raptor PharmaceuticalSEC Form 411 June 2012Common Stock · traded 8 June 2012 · filed 11 June 2012
- exercised options over 6,128 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 49 May 2012Stock options (right to buy) · traded 2 April 2012 · filed 9 May 2012
- exercised options over 6,128 shares of Raptor PharmaceuticalSEC Form 49 May 2012Common Stock · traded 2 April 2012 · filed 9 May 2012
- ▼ sold on the open market 6,128 shares of Raptor PharmaceuticalSEC Form 49 May 2012Common Stock · traded 2 April 2012 · filed 9 May 2012
- exercised options over 6,128 shares of Raptor Pharmaceutical (a derivative holding)SEC Form 44 April 2012Stock options (right to buy) · traded 2 April 2012 · filed 4 April 2012
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.